Vaccine Design: Replication-Defective Adenovirus Vectors

Area of Science:

• * Molecular biology
• * Immunology
• * Gene therapy

Background:

• * Replication-defective adenovirus (Ad) vectors were initially designed for gene transfer to correct genetic diseases.
• * Transient transgene expression and immune responses limited early gene therapy applications.
• * Ad vectors are now recognized for inducing potent T and B cell responses, making them effective vaccine carriers.

Purpose of the Study:

• * To provide guidance on developing E1-deleted adenovirus vectors.
• * To detail methods for creating and purifying Ad vectors for vaccine applications.
• * To outline quality control measures for Ad vector development.

Main Methods:

• * Utilizing available viral molecular clones for vector construction.
• * Describing procedures for viral rescue and purification.
• * Implementing quality control studies for validated vector production.

Main Results:

• * Adenovirus vectors elicit strong and lasting transgene product-specific T and B cell immunity.
• * Established protocols enable the development of E1-deleted Ad vectors.
• * Methods for cloning, rescue, purification, and quality control are detailed.

Conclusions:

• * E1-deleted adenovirus vectors are valuable tools for vaccine development due to their immunogenicity.
• * This chapter offers a practical guide for researchers working with Ad vectors.
• * Standardized methods ensure the reliable production and quality of Ad vectors for immunological studies.